Rebar Interactive founder Rahlyn Gossen was quoted in an EyeforPharma article titled, “Clinical Trials – Pharma in the Twittersphere.” Rahlyn discusses how Twitter is currently being used by clinical researchers, what makes Twitter a unique social media platform, and the opportunities Twitter offers for clinical research.
Leave a Reply